Is ribosomal capacity a potential metabolic marker of muscle development? Measurement by muscular biopsy.

Metabolic markers of muscle metabolism could help geneticists and nutritionists predict the breast meat development of chickens. The aim of the current study was to test the ribosomal capacity (CS), a potential metabolic marker, and to evaluate a simple biopsy method on the pectoralis major muscle. Ribosomal capacity was measured in three commercial meat chicken genotypes differing in their growth rate. Fast-, medium-, and slow-growing male chickens were fed using three commercial dietary programs of increasing energy and protein concentration (nine treatments). Biopsy was performed at 4 wk of age on the p. major 12 chickens per treatment. Fast-, medium-, and slow-growing chickens were slaughtered at market weight, i.e., 6, 8, and 12 wk of age, respectively, and breast meat (right and left p. major + minor) was dissected. A significant reduction in BW at slaughter (-1 to -3%) and breast meat yield (-4%) occurred only in biopsied medium-growing chickens but not in the other two types. Slow-growing chickens had a significantly lower CS (8.75 microg/mg) than the two other chicken types (9.40 and 9.46 microg/mg for fast- and medium-growing chickens, respectively). No significant dietary effect or interaction of dietary treatment with genotype was measured. The CS was not significantly correlated to breast meat development. Under conditions of the present experiment, CS may not be a relevant marker of subsequent breast meat development at 4 wk of age. The biopsy technique can easily be applied to other markers.